NYSEAMERICAN:NSPR - InspireMD Stock Price, News, & Analysis

$3.65
+0.05 (+1.39 %)
(As of 06/17/2019 04:00 PM ET)
Today's Range
$3.3405
Now: $3.65
$3.92
50-Day Range N/A
52-Week Range
$3.00
Now: $3.65
$54.50
Volume27,806 shs
Average Volume168,241 shs
Market Capitalization$4.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:NSPR
Previous SymbolNASDAQ:NSPR
CUSIPN/A
Phone+1-857-4536553

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees43
Market Cap$4.96 million
Next Earnings Date8/5/2019 (Estimated)
OptionableNot Optionable

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.

InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

When did InspireMD's stock split? How did InspireMD's stock split work?

InspireMD's stock reverse split on Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

How were InspireMD's earnings last quarter?

InspireMD Inc (NYSEAMERICAN:NSPR) announced its quarterly earnings results on Tuesday, May, 14th. The medical equipment provider reported ($3.82) EPS for the quarter, missing the Zacks' consensus estimate of ($2.50) by $1.32. The medical equipment provider had revenue of $0.42 million for the quarter, compared to analysts' expectations of $1.10 million. View InspireMD's Earnings History.

When is InspireMD's next earnings date?

InspireMD is scheduled to release their next quarterly earnings announcement on Monday, August 5th 2019. View Earnings Estimates for InspireMD.

What is the consensus analysts' recommendation for InspireMD?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for InspireMD.

Has InspireMD been receiving favorable news coverage?

News articles about NSPR stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. InspireMD earned a news impact score of 1.4 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for InspireMD.

Are investors shorting InspireMD?

InspireMD saw a increase in short interest in May. As of May 15th, there was short interest totalling 125,500 shares, an increase of 47.1% from the April 15th total of 85,300 shares. Based on an average trading volume of 270,500 shares, the short-interest ratio is presently 0.5 days. Currently, 9.6% of the company's stock are sold short. View InspireMD's Current Options Chain.

Who are some of InspireMD's key competitors?

What other stocks do shareholders of InspireMD own?

Who are InspireMD's key executives?

InspireMD's management team includes the folowing people:
  • Dr. James J. Barry, Pres, CEO & Director (Age 60)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)
  • Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)
  • Mr. Roei Samuri, VP of Operations
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 72)

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $3.65.

How big of a company is InspireMD?

InspireMD has a market capitalization of $4.96 million. InspireMD employs 43 workers across the globe.View Additional Information About InspireMD.

What is InspireMD's official website?

The official website for InspireMD is http://www.inspiremd.com/.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.


MarketBeat Community Rating for InspireMD (NYSEAMERICAN NSPR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  145 (Vote Outperform)
Underperform Votes:  138 (Vote Underperform)
Total Votes:  283
MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe NSPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Featured Article: Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel